Literature DB >> 17965656

The neuropathic pain triad: neurons, immune cells and glia.

Joachim Scholz1, Clifford J Woolf.   

Abstract

Nociceptive pain results from the detection of intense or noxious stimuli by specialized high-threshold sensory neurons (nociceptors), a transfer of action potentials to the spinal cord, and onward transmission of the warning signal to the brain. In contrast, clinical pain such as pain after nerve injury (neuropathic pain) is characterized by pain in the absence of a stimulus and reduced nociceptive thresholds so that normally innocuous stimuli produce pain. The development of neuropathic pain involves not only neuronal pathways, but also Schwann cells, satellite cells in the dorsal root ganglia, components of the peripheral immune system, spinal microglia and astrocytes. As we increasingly appreciate that neuropathic pain has many features of a neuroimmune disorder, immunosuppression and blockade of the reciprocal signaling pathways between neuronal and non-neuronal cells offer new opportunities for disease modification and more successful management of pain.

Entities:  

Mesh:

Year:  2007        PMID: 17965656     DOI: 10.1038/nn1992

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  577 in total

1.  ATP-P2X7 receptor signaling controls basal and TNFα-stimulated glial cell proliferation.

Authors:  Jian Zou; Ryan P Vetreno; Fulton T Crews
Journal:  Glia       Date:  2012-02-01       Impact factor: 7.452

Review 2.  Role of astrocytes in pain.

Authors:  C-Y Chiang; B J Sessle; J O Dostrovsky
Journal:  Neurochem Res       Date:  2012-05-26       Impact factor: 3.996

3.  Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1.

Authors:  Yong-Jing Gao; Ling Zhang; Ru-Rong Ji
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

Review 4.  Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Pharmacol Ther       Date:  2010-02-01       Impact factor: 12.310

5.  Role of microglia and astrocyte in central pain syndrome following electrolytic lesion at the spinothalamic tract in rats.

Authors:  Kobra Naseri; Elham Saghaei; Fatemeh Abbaszadeh; Mina Afhami; Ali Haeri; Farzaneh Rahimi; Masoumeh Jorjani
Journal:  J Mol Neurosci       Date:  2012-06-22       Impact factor: 3.444

6.  PPARγ Agonists Attenuate Trigeminal Neuropathic Pain.

Authors:  Danielle N Lyons; Liping Zhang; Robert J Danaher; Craig S Miller; Karin N Westlund
Journal:  Clin J Pain       Date:  2017-12       Impact factor: 3.442

Review 7.  EphBs and ephrin-Bs: Trans-synaptic organizers of synapse development and function.

Authors:  Nathan T Henderson; Matthew B Dalva
Journal:  Mol Cell Neurosci       Date:  2018-07-19       Impact factor: 4.314

8.  The prostaglandin E2 receptor EP3 controls CC-chemokine ligand 2-mediated neuropathic pain induced by mechanical nerve damage.

Authors:  Elsa-Marie Treutlein; Katharina Kern; Andreas Weigert; Neda Tarighi; Claus-Dieter Schuh; Rolf M Nüsing; Yannick Schreiber; Nerea Ferreirós; Bernhard Brüne; Gerd Geisslinger; Sandra Pierre; Klaus Scholich
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

Review 9.  [Neuropathic pain: pathophysiology, assessment, and therapy].

Authors:  C Sommer
Journal:  Schmerz       Date:  2013-12       Impact factor: 1.107

Review 10.  Epigenetic mechanisms of chronic pain.

Authors:  Giannina Descalzi; Daigo Ikegami; Toshikazu Ushijima; Eric J Nestler; Venetia Zachariou; Minoru Narita
Journal:  Trends Neurosci       Date:  2015-03-09       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.